Benjamin J. Daverman

Benjamin J. Daverman Principal

Ben joined GTCR in 2008 and became a Principal in 2014. Prior to joining GTCR, he worked as a venture capitalist at Alta Partners, as well as an investment banking Associate at JMP Securities and an Analyst in the Mergers & Acquisitions group at J.P. Morgan (formerly Hambrecht & Quist). He holds an MBA from the Wharton School at the University of Pennsylvania and a BA in History magna cum laude from Colgate University. Ben also holds a Master’s degree in Biotechnology from the School of Applied Sciences & Engineering at the University of Pennsylvania. He currently is a Director of Cole-Parmer, Crealta Pharmaceuticals, Maravai Life Sciences and Xifin. Ben was previously a Director of past GTCR investments such as Actient Pharmaceuticals, Cord Blood Registry, Devicor Medical Products, GeneraMedix and Sterigenics. In addition, Ben was involved in GTCR’s investments in Graceway Pharmaceuticals.

Ben is active in the community and serves on the executive board of Spark Program, a national non-profit that provides transformative apprenticeships for at-risk middle school students.

Phone: (312) 382-2069